The largest database of trusted experimental protocols

8050 triple quadrupole mass spectrometer

Manufactured by Shimadzu
Sourced in Japan, United States

The 8050 triple quadrupole mass spectrometer is an analytical instrument designed for sensitive and selective detection of target compounds. It features a triple quadrupole configuration to perform tandem mass spectrometry (MS/MS) analysis. The 8050 is capable of high-throughput quantitative analysis across a wide range of applications.

Automatically generated - may contain errors

28 protocols using 8050 triple quadrupole mass spectrometer

1

Quantifying Microbial TMAO Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total FMO activity in liver homogenate quantified flavin-dependent d9-TMAO production from d9-TMA using tandem mass spectrometry (LC/MS/MS) analyses using d4-choline as internal standard, as described[12 (link)]. Stable isotope dilution LC/MS/MS was used to quantify TMA, TMAO and choline in plasma and animal diets, as described[12 (link),32 (link)]. Microbial choline TMA lyase activity was quantified by monitoring d9-TMA production from d9-choline substrate using LC/MS/MS analyses[15 (link)]. Reactions were stopped by addition of methanolic acidified d4-choline and 13C3,15N1-TMA internal standard mix, and deproteinated reaction mixtures analyzed on a Shimadzu (Columbia, MD) 8050 triple quadrupole mass spectrometer with UHPLC interface.
+ Open protocol
+ Expand
2

Quantification of TMA and TMAO by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable isotope dilution high-performance LC-MS/MS was used for quantification of TMA and TMAO levels as previously described (3 (link), 44 (link)). Their d9(methyl)-isotopologues, d9-TMA and d9-TMAO, were spiked into plasma as internal standards. LC-MS/MS analyses were performed on a Shimadzu 8050 triple quadrupole mass spectrometer. TMA, TMAO, d9-TMA, and d9-TMAO were monitored using multiple reaction monitoring of precursor and characteristic product ions as follows: m/z 60.2 44.2 for TMA; m/z 69.0 49.1 for d9-TMA; m/z 76.0 58.1 for TMAO; and m/z 85.0 66.2 for d9-TMAO.
+ Open protocol
+ Expand
3

Quantitative Lipidomics Protocol for SARS-CoV-2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Concentrated samples (500 µL) were denatured with 500 µL of LC‐MS–grade MeOH containing the internal standards then warmed at 60º Celsius for 30 minutes to inactivate SARS‐CoV‐2, denatured overnight (−20° Celsius), and then centrifuged (10,000 g) to remove the denaturated proteins. Under these conditions, no significant degradation of internal standards and selected lipids and lipid mediators was observed (Figure S1). Supernatants were diluted with water containing 0.01% acetic acid and lipids were extracted by solid phase extraction using Strata‐X cartridges (Polymeric Reversed Phase, Phenomenex, USA) as described before.12 Lipids were separated using the same column and LC program as in,12 quantification was done using a Shimadzu 8050 triple quadrupole mass spectrometer and analyses were performed using multiple reaction monitoring for the specific mass transitions of each lipid as well as the deuterated internal standard used (Table S2). Due to the large number of analytes being quantitated and/or commercial availability, some lipid mediators were analyzed with a surrogate, deuterated internal standard.
+ Open protocol
+ Expand
4

Quantitative Analysis of Gut Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable isotope dilution high-performance liquid chromatography with on-line tandem mass spectrometry (LC-MS/MS) was used for quantification of levels of TMAO, TMA, choline, carnitine, betaine, and γ-butyrobetaine in plasma, as previously described (Wang et al., 2014a (link)). Their d9(methyl) isotopologues were used as internal standards. LC-MS/MS analyses were performed on a Shimadzu 8050 triple quadrupole mass spectrometer. IMC and d2-IMC, along with other metabolites, were monitored using multiple reaction monitoring of precursor and characteristic product ions as follows: m/z 230.0 → 58.0 for IMC; m/z 232.0 → 60.1 for d2-IMC; m/z 76.0 → 58.1 for TMAO; m/z 85.0 → 66.2 for d9-TMAO; m/z 60.2 → 44.2 for TMA; m/z 69.0 → 49.1 for d9-TMA; m/z 104.0 → 60.1 for choline; m/z 113.1 → 69.2 for d9-choline; m/z 118.0 → 58.1 for betaine; m/z 127.0 → 66.2 for d9-betaine.
+ Open protocol
+ Expand
5

Quantification of Metabolites by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Levels of endogenous and isotope labeled γBB and TMAO were determined as previously described by stable isotope dilution liquid chromatography–tandem mass spectrometry (LC-MS/MS) in positive ion multiple reaction monitoring (MRM) mode using a Shimadzu 8050 triple quadrupole mass spectrometer with ultra-HPLC interface.6 (link),8 (link) High-sensitivity C-reactive protein, plasma glucose, hemoglobin A1C, creatinine and lipid profiles were measured on the Roche Cobas platform (Roche Diagnostics). Laboratory personnel performing clinical and mass spectrometry analyses were blinded to sample group allocation and clinical data during analysis.
+ Open protocol
+ Expand
6

TMAO Quantification Protocol Using LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting blood samples were collected in EDTA tubes, processed to isolate plasma, and frozen at −80 °C until analysis. TMAO levels were measured using stable isotope dilution liquid chromatography with online tandem mass spectrometry using an 8050 triple quadrupole mass spectrometer (Shimadzu Scientific Instruments, Columbia, MD, USA) as previously described [1 (link),31 (link)]. The TMAO assay showed good inter- and intraday stability (CVs < 7%), accuracy (>98.5%), and stability across freeze–thaw cycles (intercycle CV < 9%) [31 (link)].
+ Open protocol
+ Expand
7

Lipid Extraction and Quantification of eCBome Mediators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipids were extracted from tissue samples according to the Bligh and Dyer method [21 (link)], as previously described [16 (link),20 (link)].
The quantification of eCBome-related mediators (Supplementary Table S1), was carried out by HPLC interfaced with the electrospray source of a Shimadzu 8050 triple quadrupole mass spectrometer using multiple reaction monitoring in positive ion mode for the compounds and their deuterated homologs. In the case of unsaturated monoacylglycerols, the data are presented as 2-monoacylglycerols (2-MAGs) but represent the combined signals from the 2- and 1(3)-isomers since the latter are most likely generated from the former via acyl migration from the sn-2 to the sn-1 or sn-3 position.
+ Open protocol
+ Expand
8

Analysis of Trace-Level Drugs in Wastewater

Check if the same lab product or an alternative is used in the 5 most similar protocols
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was employed to analyze low (ppt to ppb) drug levels in extracted wastewater influent samples. A complete list of all targeted compounds is located in SI Tables 1 and 2. All LC-MS/MS data were collected using a Shimadzu 8050 triple quadrupole mass spectrometer, operating in the positive electrospray mode (ESI+), coupled to a Nexera HPLC (Shimadzu; Kyoto, Japan). Analyte separations were achieved using a Phenomenex (Torrance, CA) Kinetex Phenyl-Hexyl reversed phase HPLC column (50 × 4.6 mm, 2.6 μm), and corresponding guard column. The HPLC column, and guard column, were kept at 40 °C throughout all chromatographic runs. Mobile phase A was 0.1% ammonium formate in water and mobile phase B was 0.1% FA in MeOH. An injection volume of 15 μL and total flow rate of 0.700 mL min−1 were used. Retention times, precursor ions, and product ions monitored for the non-labeled compounds are listed in SI Table 1, and the labeled compounds are listed in SI Table 2. More details, on the LC-MS/MS method can be found in the SI file.
+ Open protocol
+ Expand
9

Quantifying Endocannabinoid Metabolome

Check if the same lab product or an alternative is used in the 5 most similar protocols
eCBome mediators were extracted from V1 and V7 plasma samples of a total of 23 participants (13 placebo and 10 CAE). Sample processing and LC–MS/MS parameters were exactly as described by Turcotte and collaborators [47 (link)]. The quantification of eCBome-related mediators (Table S2) was carried out by an HPLC system interfaced with the electrospray source of a Shimadzu 8050 triple quadrupole mass spectrometer and using multiple reaction monitoring in positive ion mode for the compounds and their deuterated homologs.
In the case of unsaturated monoacylglycerols, the data are presented as 1/2-monoacylglycerols (2-MAGs) but represent the combined signals from the 2- and 1(3)-isomers since the latter were most likely generated from the former via acyl migration from the sn-2 to the sn-1 or sn-3 position.
+ Open protocol
+ Expand
10

Gnotobiotic communities and stable isotope

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two weeks after colonization with the indicated gnotobiotic communities animals were orally gavaged with d3-L-carnitine (150 mM; Cambridge Isotopes) and d9-γBB (150 mM; synthesized as described)8 (link) (150 µl) in a biological safety cabinet. Blood was collected from saphenous vein into a heparinized capillary tube at the indicated time points. Whole blood was centrifuged for the collection of plasma. Plasma was stored at −80 °C until analysis. Plasma levels of endogenous and stable isotope–labeled L-carnitine, γBB, and TMAO were determined by stable isotope dilution liquid chromatography–tandem mass spectrometry (LC-MS/MS) in positive multiple reaction monitoring (MRM) mode as previously described using a Shimadzu 8050 triple quadrupole mass spectrometer with ultra-HPLC interface.6 (link),21 (link) Laboratory personnel performing MS analyses were blinded to sample group allocation and clinical data during analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!